Every day fuels HEMO's ascension6 Oct 2025 11:54
The progress Hemogenyx have made on their comparatively minuscule budget is nothing short of astounding. The milestones being regularly ticked off by HEMO are substantial. Todays IRB approval to proceed with the paediatric trial and to dose children, Vlad himself confirms its significance in the RNS – and he doesn’t do overplaying anything.
So after only 2 patients safety and early efficacy data MDA deemed it exceptional enough to submit the paperwork to FDA to amend the protocol and add paediatrics. As we know, FDA agreed to this request. MDA have multiple AML trials on the go and I can’t see any other trial they’re involved in expanding to kids.
Truly ground-breaking and astounding stuff and an indication how good (safe and efficacious) HEMO CAR T already looks.
Then you get IRB approval from MD Anderson announced today, the foremost cancer research and treatment centre in the world, to begin the paediatric trial for real. Some kids will be in the hospital at MDA Houston, being cared for as best they can but without any effective treatment to improve their outlook. This approval to proceed after IRB at MDA means that children with very little hope are suddenly going to be thrown a lifeline. A chance at being fixed. I for one think this is truly fantastic.
If Dr Short at MDA was rushing to get the paediatric trial approved so quickly with FDA. If the FDA are happy to sign off the paediatric protocol amendment so early on such limited data. If FDA were happy to sign off the treatment of patient 3 when outside typical protocol granting special permission. Then who is to say Big Pharma are not making early moves now in relation to rushing to secure such an exciting and novel asset?
And yes, it is novel. It is ground-breaking. HG CT 1 has hit so many firsts already on its trial journey it is blazing a trail and maybe it feels too good to be true for observers looking in or the under researched. I personally believe Hemo have a CAR T treatment worth in excess of a billion pounds and only expect the excitement to grow from here.
Agree with SocialistB, seeing Vlad's treatment begin to help more and more people, changing lives, as well as seeing such amazing work drive up the share price of your investment... It doesn't get much better imo.
Good luck all shareholders.